Impact of Smoking Status on Perioperative Morbidity, Mortality, and Long-Term Survival Following Transthoracic Esophagectomy for Esophageal Cancer

被引:19
|
作者
Kamarajah, Sivesh K. [1 ,2 ]
Madhavan, Anantha [1 ]
Chmelo, Jakub [1 ]
Navidi, Maziar [1 ]
Wahed, Shajahan [1 ]
Immanuel, Arul [1 ]
Hayes, Nick [1 ]
Griffin, S. Michael [1 ]
Phillips, Alexander W. [1 ,3 ]
机构
[1] Newcastle Univ Trust Hosp, Royal Victoria Infirm, Northern Oesophagogastr Unit, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Univ, Sch Med Educ, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
10.1245/s10434-021-09720-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Esophagectomy is a key component in the curative treatment of esophageal cancer. Little is understood about the impact of smoking status on perioperative morbidity and mortality and the long-term outcome of patients following esophagectomy. Objective This study aimed to evaluate morbidity and mortality according to smoking status in patients undergoing esophagectomy for esophageal cancer. Methods Consecutive patients undergoing two-stage transthoracic esophagectomy (TTE) for esophageal cancers (adenocarcinoma or squamous cell carcinoma) between January 1997 and December 2016 at the Northern Oesophagogastric Unit were included from a prospectively maintained database. The main explanatory variable was smoking status, defined as current smoker, ex-smoker, and non-smoker. The primary outcome was overall survival (OS), while secondary outcomes included perioperative complications (overall, anastomotic leaks, and pulmonary complications) and survival (cancer-specific survival [CSS], recurrence-free survival [RFS]). Results During the study period, 1168 patients underwent esophagectomy for cancer. Of these, 24% (n = 282) were current smokers and only 30% (n = 356) had never smoked. The median OS of current smokers was significantly shorter than ex-smokers and non-smokers (median 36 vs. 42 vs. 48 months; p = 0.015). However, on adjusted analysis, there was no significant difference in long-term OS between smoking status in the entire cohort. The overall complication rates were significantly higher with current smokers compared with ex-smokers or non-smokers (73% vs. 66% vs. 62%; p = 0.018), and there were no significant differences in anastomotic leaks and pulmonary complications between the groups. On subgroup analysis by receipt of neoadjuvant therapy and tumor histology, smoking status did not impact long-term survival in adjusted multivariable analyses. Conclusion Although smoking is associated with higher rates of short-term perioperative morbidity, it does not affect long-term OS, CSS, and RFS following esophagectomy for esophageal cancer. Therefore, implementation of perioperative pathways to optimize patients may help reduce the risk of complications.
引用
收藏
页码:4905 / 4915
页数:11
相关论文
共 50 条
  • [41] Long-term prostate cancer mortality, all-cause survival and morbidity following prostate brachytherapy
    Skouteris, V
    Stone, N.
    Sheu, R-D
    Stock, R.
    EUROPEAN UROLOGY, 2022, 81 : S1396 - S1397
  • [42] Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy
    Ovrebo, Kjell K.
    Lie, Stein A.
    Laerum, Ole D.
    Svanes, Knut
    Viste, Asgaut
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [43] Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy
    Kjell K Ovrebo
    Stein A Lie
    Ole D Laerum
    Knut Svanes
    Asgaut Viste
    World Journal of Surgical Oncology, 10
  • [44] The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer
    Wong, Lye-Yeng
    Liou, Douglas Z.
    Backhus, Leah M.
    Lui, Natalie S.
    Shrager, Joseph B.
    Berry, Mark F.
    JTCVS OPEN, 2023, 14 : 547 - 560
  • [45] Esophagectomy Complications Impact Long-term Survival A National Cancer Database Analysis
    Sachidananda, Sandeep
    Timsina, Lava
    Namburi, Niharika
    Birdas, Thomas J.
    ANNALS OF SURGERY, 2023, 277 (03) : 437 - 441
  • [46] Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer A Nationwide Retrospective Analysis
    Sakamoto, Takashi
    Fujiogi, Michimasa
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    ANNALS OF SURGERY, 2021, 274 (02) : 324 - 330
  • [47] Effect of perioperative flurbiprofen axetil on long-term survival of patients with esophageal carcinoma who underwent thoracoscopic esophagectomy
    Sun, Jing
    Hu, Qiang
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (08) : 1572 - 1574
  • [48] Perioperative Morbidity Affects Long-Term Survival in Patients Following Liver Resection for Colorectal Metastases
    M. Schiesser
    J. W. C. Chen
    G. J. Maddern
    R. T. A. Padbury
    Journal of Gastrointestinal Surgery, 2008, 12 : 1054 - 1060
  • [49] Impact of diabetes on long-term survival and morbidity following aortic aneurysm repair
    Lareyre, Fabien
    Raffort, Juliette
    JOURNAL OF VASCULAR SURGERY, 2020, 71 (01) : 352 - 352
  • [50] Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases
    Schiesser, M.
    Chen, J. W. C.
    Maddern, G. J.
    Padbury, R. T. A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (06) : 1054 - 1060